Adhesive Escherichia coli in inflammatory bowel disease and infective diarrhoea - PubMed (original) (raw)
Adhesive Escherichia coli in inflammatory bowel disease and infective diarrhoea
D A Burke et al. BMJ. 1988.
Abstract
The clinical features of ulcerative colitis and Crohn's disease are similar to those of infections of the bowel, although their cause is uncertain. Many bacteria that cause intestinal diseases adhere to the gut mucosa, and adhesion of pathogenic Escherichia coli is resistant to D-mannose. The adhesive properties of isolates of E coli were assessed by assay of adhesion to buccal epithelial cells with mannose added. The isolates were obtained from patients with inflammatory bowel diseases (50 with a relapse of ulcerative colitis, nine with ulcerative colitis in remission, 13 with Crohn's disease, and 11 with infectious diarrhoea not due to E coli) and 22 controls. The median index of adhesion to buccal epithelial cells (the proportion of cells with more than 50 adherent bacteria) for E coli from patients with ulcerative colitis in relapse was significantly higher (43%) than that for controls (5%) and patients with infectious diarrhoea (14%). The index was not significantly different among isolates from patients with ulcerative colitis in relapse, Crohn's disease (53%), and ulcerative colitis in remission (30%). If an index of adhesion of greater than 25% is taken as indicating an adhesive strain 86% of isolates of E coli from patients with inflammatory bowel disease were adhesive compared with 27% from patients with infective diarrhoea and none from controls. The adhesive properties of the isolates from patients with inflammatory bowel disease were similar to those of pathogenic intestinal E coli, raising the possibility that they may have a role in the pathogenesis of the condition; the smaller proportion of adhesive isolates in patients with infective diarrhoea due to other bacteria suggests that the organism may be of primary importance rather than arising secondarily.
Similar articles
- Virulence properties of Escherichia coli strains isolated from patients with inflammatory bowel disease.
Giaffer MH, Holdsworth CD, Duerden BI. Giaffer MH, et al. Gut. 1992 May;33(5):646-50. doi: 10.1136/gut.33.5.646. Gut. 1992. PMID: 1612481 Free PMC article. - Ulcerative colitis and Escherichia coli with adhesive properties.
Burke DA, Axon AT. Burke DA, et al. J Clin Pathol. 1987 Jul;40(7):782-6. doi: 10.1136/jcp.40.7.782. J Clin Pathol. 1987. PMID: 3305586 Free PMC article. - The prevalence of mucosa-associated diffusely adherent Escherichia coli in children with inflammatory bowel disease.
Walczuk U, Sobieszczańska B, Turniak M, Rzeszutko M, Duda-Madej A, Iwańczak B. Walczuk U, et al. Adv Clin Exp Med. 2019 Jul;28(7):899-905. doi: 10.17219/acem/94149. Adv Clin Exp Med. 2019. PMID: 31066244 - [The role of Escherichia coli strain Nissle 1917 in the gastro-intestinal diseases].
Różańska D, Regulska-Ilow B, Choroszy-Król I, Ilow R. Różańska D, et al. Postepy Hig Med Dosw (Online). 2014 Nov 6;68:1251-6. doi: 10.5604/17322693.1127882. Postepy Hig Med Dosw (Online). 2014. PMID: 25380207 Review. Polish. - Role of antibiotics for treatment of inflammatory bowel disease.
Nitzan O, Elias M, Peretz A, Saliba W. Nitzan O, et al. World J Gastroenterol. 2016 Jan 21;22(3):1078-87. doi: 10.3748/wjg.v22.i3.1078. World J Gastroenterol. 2016. PMID: 26811648 Free PMC article. Review.
Cited by
- Role of bacteria in the etiopathogenesis of inflammatory bowel disease.
Barnich N, Darfeuille-Michaud A. Barnich N, et al. World J Gastroenterol. 2007 Nov 14;13(42):5571-6. doi: 10.3748/wjg.v13.i42.5571. World J Gastroenterol. 2007. PMID: 17948930 Free PMC article. Review. - Bacteria as the cause of ulcerative colitis.
Campieri M, Gionchetti P. Campieri M, et al. Gut. 2001 Jan;48(1):132-5. doi: 10.1136/gut.48.1.132. Gut. 2001. PMID: 11115835 Free PMC article. Review. No abstract available. - HtrA stress protein is involved in intramacrophagic replication of adherent and invasive Escherichia coli strain LF82 isolated from a patient with Crohn's disease.
Bringer MA, Barnich N, Glasser AL, Bardot O, Darfeuille-Michaud A. Bringer MA, et al. Infect Immun. 2005 Feb;73(2):712-21. doi: 10.1128/IAI.73.2.712-721.2005. Infect Immun. 2005. PMID: 15664909 Free PMC article. - Escherichia coli Pathobionts Associated with Inflammatory Bowel Disease.
Mirsepasi-Lauridsen HC, Vallance BA, Krogfelt KA, Petersen AM. Mirsepasi-Lauridsen HC, et al. Clin Microbiol Rev. 2019 Jan 30;32(2):e00060-18. doi: 10.1128/CMR.00060-18. Print 2019 Mar 20. Clin Microbiol Rev. 2019. PMID: 30700431 Free PMC article. Review. - Serum bactericidal resistance of faecal Escherichia coli and bactericidal competence of serum from patients with ulcerative colitis.
Burke DA, Clayden SA, Axon AT. Burke DA, et al. J Clin Pathol. 1990 Apr;43(4):316-9. doi: 10.1136/jcp.43.4.316. J Clin Pathol. 1990. PMID: 2187904 Free PMC article.
References
- Lancet. 1975 Nov 15;2(7942):946-8 - PubMed
- Infect Immun. 1975 Sep;12(3):656-67 - PubMed
- Gastroenterology. 1977 Feb;72(2):220-7 - PubMed
- Lancet. 1978 Jan 7;1(8054):1-5 - PubMed
- Infect Immun. 1978 Feb;19(2):727-36 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical